The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Your logic based on the numbers you quote is sound enough Sean. Perhaps a little simplistic but it’s sound.
It’s the previous shenanigans and continuing up beat narrative that causes me concern.
They’ve just announced a placing at a 50% discount! Long term holders got well and truly burned. A question I ask myself is “am I buying because I like the long term prospects of the company or am I buying because I feel pressured into trying to protect my original investment.
I have only a very small holding and I’ve no desire to increase it even at a small ( in monetary terms) paper profit.
I will keep a watching brief here but I’ve been diluted to the point were I’ll not lose any sleep over it.
I believe there’s better opportunities out there particularly in rare earths and I’m certain you’ll see a consolidation here fairly quickly.
It’s just not for me Sean.
AA 4 Corners and Sean.
You all raise valid points and I read them with interest. My “billions” statement was an exaggeration to prove a point.
My rationale is simple.
I’ve taken up these offers in the past with very mixed fortunes. Ultimately the market will decide based on the success of the open offer and any potential fund raise. I have known prices to fall below the offer price on many occasions in the past. Perhaps not always immediately but it’s certainly not a given that 3p is sustainable in the short term.
The over riding factors in this for me are;
my belief in the company’s potential,
the previous activities of SF and their cohorts
and whether I have faith in them to deliver for PIs.
Agreed 4corners. Buy into an allocation in a company with billions of shares issued. Then when the inevitable consolidation is announced, if you’re very lucky you’re back to your original holding but at a greater cost. Not for me! I’m writing this off.
Agreed Lactic. And at that time any test that picked up even 50% of positive cases was a lot better than no test at all.
The game has changed now. We have a test. An accurate test and a test that’s sovereign.
It’s taken time but Smith refused to go for the quick buck. The reputation of the company’s product entire portfolio depended on it. The extent of the transformation of the company remains to be seen but I’m going nowhere for a long time yet.
Would the outside agency have come clean without the Twitter leak?
When did they tell Mologic they’d screwed up?
DID they tell Mologic they’d screwed up ?
If Mologic knew at what point did they tell Avacta?
Did Avacta only find out over the Bank Holiday weekend.
Did Julie lose her job because of all this?
What a mess.
I’m a holder since March last year and I’ll be a holder in March next year because this company is going places.
Have faith Smith will deliver.
I couldn’t work out which company produces this test. Some clues towards the end of the piece. Looks like Roche have made it to market but it’s of no concern if the accuracy is as projected.
https://www.leinsterrugby.ie/leinster-rugby-announce-plans-for-rapid-antigen-testing-pilot/?fbclid=IwAR2mQrEovQcmCAXbk6iX2DWG6bq7tA1FHhfH6aEP2JlIgA8r9goCV6hXlVs
CE marking and production of LFT imminent. Capacity of several millions per month. We will sell as many as we can make.
Anyone who has been here long term has leant to wait and profited from being patient.
Hell even I can wait until March!!
Yes indeed Camkite. It is for the reasons you express that I find a degree of comfort here now. SF successfully delivered what amounted to a commercial coup. I am confident they will renegotiate a loan package with their funders. What happens longer term remains to be seen. But I am a little more optimistic of seeing a turnaround. I wonder if a merger would be beneficial for both companies.
I have always been very sceptical about SF’s motives here. Rather than drive GMS into administration as some have suggested, I wonder if a merger between SF and GMS might be on the cards. Any resultant admin savings and operational efficiencies could possibly assist to broker better future loan arrangements.
I completely agree Zoom. In reality, despite the update this morning, we have only recovered the down turn from last week. I expect the market won’t react properly until revenues start to flow. Not too long now. Happy to hold and wait patiently.
I’ve had a little dabble here myself. It’s an interesting share with lots of potential for growth long term. I’ll be looking in from time to time but meantime happy to hold and await updates and further developments.
An amazing gentleman. The last two years of his life were incredible. Sincere condolences to his family and friends. He will be remembered as the epitome of everything that is great and caring about this United Kingdom.
Hey sleepy,
Many years ago someone told me a great investment strategy was to buy shares in innovative companies with real long term growth potential.....then put them away and forget about them.
Last year he drank himself to death sitting in his Chateau in France.
Hell......I’ve been here since March. How long must I wait? I don’t care. This is rock solid. See you all in the New Year.
That’ll be before “transformational” Doggy.
I didn’t buy in here as a COVID play. I invested for the cancer treatment potential but I won’t try to disguise the fact that I’m hugely disappointed by today RNS and I’m disappointed on lots of different levels.